SARAH MUNCH: Open Payments
NPI 1700990082 · PARCHMENT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,452 in 121 payments from 29 companies in 2025. Trend: 2023 $2,420 · 2024 $2,091 · 2025 $2,452
Food & beverage: $2,452
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $401 |
| Novo Nordisk Inc | 13 | $274 |
| Amgen Inc. | 14 | $220 |
| Lilly USA, LLC | 9 | $212 |
| ABBVIE INC. | 11 | $166 |
| Eisai Inc. | 10 | $159 |
| PFIZER INC. | 5 | $103 |
| Astellas Pharma US Inc | 4 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
Products named: AIRSUPRA, Ozempic, VRAYLAR, Leqembi, OTEZLA, JARDIANCE, Wegovy, Veozah.
Industry payments across MI — which companies pay providers there.
